SYT, didn't they buy that revenue?The buy was touted in 2018 to have circa $14m revenue CY17...so I wonder how the original underlying business is actually doing.be wary still.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025